← Eichor
Study identifier: NCT07380711 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

Condition: Chronic Obstructive Pulmonary Disease COPD  ·  Sponsor: Sanofi

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The OBS19236 is a retrospective and prospective, non-interventional observational study in COPD patients treated with dupilumab as part of routine clinical care. It will follow-up about 350 to 500 participants over 36 months in up to 50 sites in France.

This description comes directly from the study's public registry record.

Talk to the study team

Trial Transparency email recommended (Toll free for US & Canada)  ·  800-633-1610  ·  contact-us@sanofi.com

Always discuss trial participation with your own doctor first.

Locations (22)

Investigational Site Number : 2500021Aix-en-Provence, FranceRecruiting
Investigational Site Number : 2500043Blois, FranceRecruiting
Investigational Site Number : 2500044Brest, FranceRecruiting
Investigational Site Number : 2500009Colmar, FranceRecruiting
Investigational Site Number : 2500031Contamine-sur-Arve, FranceRecruiting
Investigational Site Number : 2500022Juan-les-Pins, FranceRecruiting
Investigational Site Number : 2500020Le Chesnay, FranceRecruiting
Investigational Site Number : 2500038Libourne, FranceRecruiting
Investigational Site Number : 2500033Lyon, FranceRecruiting
Investigational Site Number : 2500024Marseille, FranceRecruiting
Investigational Site Number : 2500002Montpellier, FranceRecruiting
Investigational Site Number : 2500047Morlaix, FranceRecruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07380711